Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therapy for Advanced Urothelial Carcinoma
Titel:
Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therapy for Advanced Urothelial Carcinoma
Auteur:
Agarwal, Neeraj Bellmunt, Joaquim Maughan, Benjamin L. Boucher, Kenneth M. Choueiri, Toni K. Qu, Angela Q. Vogelzang, Nicholas J. Fougeray, Ronan Niegisch, Guenter Albers, Peter Wong, Yu-Ning Ko, Yoo-Joung Sridhar, Srikala S. Tantravahi, Srinivas K. Galsky, Matthew D. Petrylak, Daniel P. Vaishampayan, Ulka N. Mehta, Amitkumar N. Beer, Tomasz M. Sternberg, Cora. N. Rosenberg, Jonathan E. Sonpavde, Guru